Real-world data on effectiveness of durvalumab after chemoradiotherapy

Real-world data on effectiveness of durvalumab after PACIFIC-R real-world trial confirms effectiveness of durvalumab in patients with unresectable stage III non–small cell lung cancer (NSCLC), concludes Professor Nicolas Girard in this BestPractice Nordic MEDtalk.